1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Hyperlipidemias in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amuzie, C; Avolio, A; Bedja, D; Berkowitz, D; Chatterjee, S; Kass, DA; Mishra, S; Renehan, M | 1 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Hyperlipidemias
Article | Year |
---|---|
Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet.
Topics: Animals; Antigens, CD; Aorta; Apolipoproteins E; Calcium; Cholesterol, Dietary; Coronary Artery Disease; Diet, High-Fat; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Glucosylceramides; Glycosphingolipids; Hyperlipidemias; Lactosylceramides; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Models, Cardiovascular; Morpholines; Pulsatile Flow; Rabbits; Ultrasonography; Vascular Stiffness | 2014 |